Beta-Lactam and Sulfonamide Allergy Testing Should Be a Standard of Care in Immunocompromised Hosts

JA Trubiano; MA Slavin; KA Thursky; ML Grayson; EJ Phillips

Journal article

Beta-Lactam and Sulfonamide Allergy Testing Should Be a Standard of Care in Immunocompromised Hosts

JA Trubiano, MA Slavin, KA Thursky, ML Grayson, EJ Phillips

Journal of Allergy and Clinical Immunology in Practice | ELSEVIER | Published : 2019

DOI: 10.1016/j.jaip.2019.05.051

Download PDF

Abstract

Antibiotic allergies are reported in up to 1 in 4 immunocompromised hosts with significant impacts on antibiotic utilization and patient outcomes. Health services programs focused on de-labeling beta-lactam and sulfonamide allergy labels should be a standard of care in immunocompromised hosts.

University of Melbourne Researchers

Jason Trubiano Author

Monica Slavin Author

Kas Thursky Author

Related Projects (2)

NATIONAL CENTRE FOR INFECTIONS IN CANCER (NCIC)

This Centre of Research Excellence will translate the best available evidence to improve cancer outcomes through better management of infect..

DEVELOPING AND EVALUATING A MULTIMODAL ANTIBIOTIC ALLERGY STRATEGY TO IMPROVE ANTIMICROBIAL STEWARDSHIP IN HIGH-RISK ANTIBIOTIC USAGE POPULATIONS

Antibiotic allergies lead to the use of inferior antibiotics and generation of “superbugs”. Antibiotic allergy testing removes up to 90% of ..

Grants

Awarded by National Institutes of Health

Funding Acknowledgements

This work was supported by the Austin Medical Research Foundation.J. A. Trubiano is supported by a National Health and Medical Research Council (NHMRC) postgraduate scholarship (GNT 1139902) and a postgraduate scholarship from the National Centre for Infections in Cancer, NHMRC, Centre for Research Excellence (App 1116876). E. J. Phillips receives grant support from the National Institutes of Health (award nos. 1P50GM115305-01) and the NHMRC. The rest of the authors declare that they have no relevant conflicts of interest.